From November 17 to 20, 2025, Bioer participated in MEDICA 2025 in Düsseldorf, Germany – one of the world’s most influential trade fairs for medical technology and healthcare. This year’s event brought together over 5,000 exhibitors from 72 countries and attracted more than 80,000 visitors, highlighting the global momentum of innovation in medical imaging, laboratory technology, diagnostics, health IT, mobile health, physiotherapy, orthopaedic technology, and medical consumables.
At this international stage, Bioer presented a full range of its advanced molecular diagnostic instruments, demonstrating the company’s continuous commitment to supporting laboratories with efficient, accurate, and scalable solutions. Featured products included:
PrepFlex 100 Automated Liquid Handling Workstation – delivering flexible assay setup and precise high-throughput pipetting.
AutoGene 9600 Automatic PCR Analysis System (A9600) – enabling automated sample preparation and PCR detection within one integrated workflow.
CentriDx 200 Automated Nucleic Acid Analyzer – a walk-away platform compatible with respiratory, gastrointestinal, and meningitis, STD detection kits, capable of completing multi-pathogen testing within 1 hour.
DcentriGene 160 Droplet Chip Digital PCR Analysis System – providing high-sensitivity and high-precision quantification through advanced droplet chip technology.
Throughout the exhibition, Bioer engaged with global partners, researchers, and healthcare professionals, sharing insights into how its instruments support molecular diagnostics across clinical, research, agriculture, and life science fields. Visitors showed strong interest in Bioer’s integrated workflow solutions—from sample processing to nucleic acid analysis and high-precision quantification.
For more than two decades, Bioer has remained committed to advancing molecular diagnostics through continuous innovation in instruments, reagents, and consumables. The company will continue to strengthen its international collaborations and drive forward new technologies that enhance laboratory efficiency and diagnostic accuracy.
Bioer looks forward to building on the momentum from MEDICA 2025 and continuing its mission to provide reliable, innovative molecular solutions for laboratories worldwide.